Labcorp Holdings Inc. (LH) earnings on July 30, 2026
More Labcorp Holdings Inc. earnings
Prior outlook: No statistical edge
Labcorp's quarterly profit and revenue topped estimates, and the company raised its full-year forecast. The stock closed up 2.3% after hitting an intraday high of 3.2%.
LH price around the earnings
315.53
Change: +3.0%
2026-07-30, 20:00 UTC
- Price: green if it ends above the starting price; red if it ends below
- End of the measured window
- Market open
- Starting price
Prior thesis
Prior outlook: No statistical edge
- Thesis published
- Results released
Strong past earnings and analyst upgrades, but recent rally suggests after a strong recent rise conditions and limited optimistic scenario.
Context analyzed before publication
- Trend
- Strong 14d run-up (+12.92%) into earnings, suggesting after a strong recent rise conditions and potential sell-the-news risk.
Analysts
Evidence
- Analyst consensus
- Buy
- Consensus average (1-5)
- 1.63
- Analysts covering the stock
- 17
- Average price target
- 312.35
- Lowest price target
- 270
- Highest price target
- 340
- Upside to price target
- 1.7%
- Quarterly earnings growth
- 30.5%
- Revenue growth
- 5.8%
- Forward EPS
- 19.41
- Trailing EPS
- 11.03
- Analyst moves in the last 60 days
- 2
- Strong buy: 2
- Buy: 12
- Hold: 5
- Sell: 0
- Strong sell: 0
- Strong buy
- 2
- Buy
- 12
- Hold
- 5
- Sell
- 0
- Strong sell
- 0
- July 13, 2026 · B of A Securities: Maintains rating (Buy → Buy)
- July 13, 2026 · Baird: Maintains rating (Outperform → Outperform)
News and sentiment
Evidence
Sentiment
- Sentiment
- Constructive
- Mention volume
- Low
- Normalized volume
- 33%
News
Sources (2)
- B of A Securities Maintains Buy on Labcorp Holdings, Raises Price Target to $320 (opens in a new tab) — Benzinga
- Baird Maintains Outperform on Labcorp Holdings, Raises Price Target to $338 (opens in a new tab) — Benzinga
Technicals
Evidence
- Price when the context was analyzed
- 307
- Average true range (ATR)
- 2.7%
- Distance to 52-week high
- -2.3%
- 14-day change (14d)
- +12.9%
- 30-day change (30d)
- +9.8%
- 30-day relative strength
- +11.3%
- SPY change (30d)
- -1.5%
- Nearest support
- 306.91
- Distance to nearest support
- 0%
- Nearest resistance
- 310
- Distance to nearest resistance
- 1%
- Volume accumulation ratio (14d / 46d)
- 1.47
- Minor: 306.91 (0% away, 0.01 ATR, 1 touches)
- Mid: 302.92 (1.3% away, 0.49 ATR, 2 touches)
- Mid: 301 (2% away, 0.71 ATR, 3 touches)
- Minor: 310 (1% away, 0.36 ATR, 2 touches)
- Minor: 314.23 (2.4% away, 0.86 ATR, 2 touches)
- Mid: 316.2 (3% away, 1.1 ATR, 3 touches)
Trends
Evidence
- Average earnings surprise
- +3.0%
- April 30, 2026: actual EPS 4.25 vs estimate 4.12 (surprise +3.3%)
- February 17, 2026: actual EPS 4.07 vs estimate 3.94 (surprise +3.3%)
- October 28, 2025: actual EPS 4.18 vs estimate 4.14 (surprise +1.0%)
- July 24, 2025: actual EPS 4.35 vs estimate 4.16 (surprise +4.5%)
Expected move
- Implied move
- +1.9%
- Source
- Options chain
Reactions over its last 20 earnings
- Median move
- 4.1%
- 75th percentile move
- 5%
- 90th percentile move
- 6.1%
- Up / down moves
- 10 / 10
- Average up move
- +3.9%
- Average down move
- -3.3%
Monitoring and close
What Labcorp Holdings Inc. reported
- Status
- Finished
| Actual EPS | 4.99 |
|---|---|
| EPS estimate | 4.78 |
| EPS surprise | +4.4% |
| Revenue | $3,731 million |
| Revenue estimate | $3,711 million |
| Revenue surprise | +0.5% |
Labcorp reported better-than-expected Q2 earnings, but shares fell 6%. The 2026 outlook remains optimistic.
Sources (9)
- LH Stock Down Despite Q2 Earnings and Revenue Beat, Margins Rise (opens in a new tab) — Zacks
- Labcorp Holdings Inc. (LH) Q2 2026 Earnings Call Transcript (opens in a new tab) — SeekingAlpha
- Labcorp (LH) Reports Q2 Earnings: What Key Metrics Have to Say (opens in a new tab) — Zacks
- Labcorp (NYSE:LH) Reports Q2 CY2026 In Line With Expectations (opens in a new tab) — StockStory
- Labcorp Holdings (LH) Surpasses Q2 Earnings and Revenue Estimates (opens in a new tab) — Zacks
- Labcorp (NYSE:LH) Shares Slide on Q2 Revenue Miss Despite Earnings Beat (opens in a new tab) — ChartMill
- Labcorp Holdings Raises FY2026 Adj EPS Guidance from $17.70-$18.35 to $18.10-$18.55 vs $18.01 Est; Raises FY2026 Sales Guidance from $14.650B-$14.800B to $14.710B-$14.827B vs $14.707B Est (opens in a new tab) — Benzinga
- Laboratory Corp reported adjusted earnings of $4.99 per share, beating the $4.78 estimate, and revenue of $3.731B, above the $3.711B forecast. — Benzinga
- Labcorp Announces 2026 Second Quarter Results; Raises Full Year 2026 Guidance (opens in a new tab) — Yahoo
Pre-market second reading after the results
- Verdict
- Beat expectations
Heading into the open, results beat expectations on both earnings and revenue, and the price is indicating a 3.9% drop pre-market, a move in line with the stock's typical reaction (about 4%). The figures do not confirm the prior scenario: there was no prior directional scenario to check against.
How the stock reacted
- Consolidated
- +2.3%
- Max move
- -5.4%
No verdict: the outlook took no direction, so there is nothing to score as a hit or a miss.